Xencor Launches $110M Public Offering

Monrovia-based biotechnology developer Xencor has launched a public offering of its common stock, with the aim of raising approximately $110M in funding, the company said on Wednesday. The publicly traded biotechnology developer--which trades on the NASDAQ as XNCR--said it has priced the offering at $24.000 per share. The company said the new funding will go towards working capital and general corporate purposes, including investing in its pipeline and lead compoound.